Acute Toxic Leukoencephalopathy: Etiologies, Imaging Findings, and Outcomes in 101 Patients
Open Access
- 24 January 2019
- journal article
- research article
- Published by American Society of Neuroradiology (ASNR) in American Journal Of Neuroradiology
- Vol. 40 (2), 267-275
- https://doi.org/10.3174/ajnr.a5947
Abstract
BACKGROUND AND PURPOSE: Prior studies regarding acute toxic leukoencephalopathy (ATL) are either small, or preliminary. Our aim was to evaluate etiologies of and differences in imaging severity and outcomes among various etiologies of ATL. MATERIALS AND METHODS: MRIs of patients with suspected ATL over 15 years were retrospectively reviewed; inclusion criteria were: MRI 6 patients were statistically compared. RESULTS: Of 101 included patients, the 4 subgroups of n > 6 were the following: chemotherapy (n = 35), opiates (n = 19), acute hepatic encephalopathy (n = 14), and immunosuppressants (n = 11). Other causes (n = 22 total) notably included carbon monoxide (n = 3) metronidazole (n = 2), and uremia (n = 1). The mean DWI/FLAIR severity scores were 2.6/2.3, 3.3/3.3, 2.1/2.1 and 2.0/2.5 for chemotherapeutics, opiates, AHE and immunosuppressants, respectively, with significant differences in both imaging severity and outcome (P = .003–.032) among subgroups, particularly immunosuppressant versus chemotherapy-related ATL and immunosuppressants versus opiates (P = .004–.032) related ATL. DWI and FLAIR severity weakly correlated with outcome (ρ = 0.289–.349, P < .005) but correlated stronger in the chemotherapy (ρ = 0.460–.586, P < .010) and opiate (ρ =.472–.608, P < .05) subgroups, which had the worst outcomes. ATL clinically resolved in 36%, with severe outcomes in 23% (coma or death, 9/16 deaths from fludarabine). Notable laboratory results were elevated CSF myelin basic protein levels in 8/9 patients and serum blood urea nitrogen levels in 24/91. CONCLUSIONS: Clinical outcomes of ATL vary on the basis of etiology, being worse in chemotherapeutic- and opiate-related ATL. Uremia may be a predisposing or exacerbating factor.Keywords
This publication has 33 references indexed in Scilit:
- Toxic Leukoencephalopathies, Including Drug, Medication, Environmental, and Radiation-Induced Encephalopathic SyndromesSeminars in Ultrasound, CT and MRI, 2014
- Toxic Leukoencephalopathy following Fludarabine-Associated Hematopoietic Cell TransplantationTransplantation and Cellular Therapy, 2011
- Acute Hepatic Encephalopathy: Diffusion-Weighted and Fluid-Attenuated Inversion Recovery Findings, and Correlation with Plasma Ammonia Level and Clinical OutcomeAmerican Journal of Neuroradiology, 2010
- Acute Toxic Leukoencephalopathy: Potential for Reversibility Clinically and on MRI With Diffusion-Weighted and FLAIR ImagingAmerican Journal of Roentgenology, 2009
- Posterior Reversible Encephalopathy Syndrome: Incidence of Atypical Regions of Involvement and Imaging FindingsAmerican Journal of Roentgenology, 2007
- MR Imaging of Metronidazole-Induced Encephalopathy: Lesion Distribution and Diffusion-Weighted Imaging FindingsAmerican Journal of Neuroradiology, 2007
- Reversible findings of restricted diffusion in 5‐flourouracil neurotoxicityAustralasian Radiology, 2006
- Neuroimaging Features of Heroin Inhalation Toxicity: “Chasing the Dragon”American Journal of Roentgenology, 2003
- Diffusion-weighted MR imaging findings in carbon monoxide poisoningNeuroradiology, 2002
- Toxic LeukoencephalopathyThe New England Journal of Medicine, 2001